Skip to content
ACTA – Australian Clinical Trials Alliance
  • About
  • Activities
  • News
  • Resources
  • Events
  • Membership
  • Forum
  • Contact Us
  1. Home
  2. Activities

Activities

Expert investigators work to strengthen and support clinical trial networks, coordinating centres and registries. ACTA has eight active Reference Groups and two Special Interest Groups.

Find out more about these groups, as well as ACTA’s work in advocating for and informing the sector in the sections below.

Become an ACTA Member
Activity at ACTA - reference groups
  • Member Stories

    ACTA profiles its Members and the exceptional work they do in clinical trials and registries.

    Learn More
    ACTA audience
  • Registry Randomised Trials: Key Methodology Issues Workshop

    ACTA held a virtual workshop in May 2020 for key stakeholders to respond to and address the barriers to the uptake of registry randomised trials.…

    Learn More
  • Efficient and Effective Clinical Trial Networks

    Recent group activities: The Efficient and Effective Clinical Trial Networks Reference Group has been creating a suite of resources and tools for clinical trials networks,…

    Learn More
  • Clinical Trial Network Sector Expansion

    Recent group activities: The group has created resources for new clinical trials networks, now available in the resource area of this website. Establishment of New…

    Learn More
  • Impact and Implementation of Clinical Trial Networks

    Recent group activities: Scope and definitions of the group were developed by leadership group early 2018Impact and Implementation forum held in August 2018 with national…

    Learn More
  • Embedding Clinical Trials in Healthcare

    Recent group activities Consensus definition of embedding clinical trials in healthcareInternational Best Practice Towards a Learning Healthcare System: A scoping activity to map international approaches…

    Learn More
  • Strengthening Consumer Engagement in Clinical Trials

    Recent group activities International Best Practice of Consumer Involvement in Research: Discussion PaperConsumer Involvement in Clinical Trials: Consultation ReportWorkshop: Consumer Involvement & Engagement Toolkit –…

    Learn More
  • Tools and Criteria for Research Prioritisation

    Recent group activities An overview of medical research prioritisation for Clinical Trial NetworksA consultation survey of approaches and attitudes to prioritisation of clinical trials among…

    Learn More
  • Innovative Trial Design

    Recent group activities: Most of the outputs for this group are academic and educational events. In early 2019 this reference group held a number of…

    Learn More
  • Innovative Outcome Data

    Recent group activities The group is also involved in academic and educational events—’Summer School’ events include:Registry-Randomised Trials Colloquium, one-day (ADE)Webinars held include:Data Linkage (1 of…

    Learn More
  • Statistics in Trials Interest Group (STInG)

    The executive committee of this group is very engaged and meets frequently to advance projects of this group. STInG has no activity funding, so the…

    Learn More
    Juggling percentages
  • Registries Special Interest Group

    The Registries Special Interest Group is Chaired by Prof Stephen McDonald, ANZDATA Registry executive and renal physician, and its Board Sponsor is Prof John Zalcberg.…

    Learn More
  • SIGNet

    SIGNet is ACTA’s Special Interest Group for Network Managers. Each Clinical Trial Network may nominate a representative on SIGNet. SIGNet provides a forum for Executive…

    Learn More
  • Advocacy

    ACTA is the peak body for clinical trial networks, clinical quality registries and clinical trial coordinating centres in Australia. We represent the investigator-initiated clinical trials…

    Learn More
    Working together to achieve our aims
  • COVID-19

    We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.  

    Learn More
    Image of COVID-19 virus

Main navigation

  • About
  • Activities
  • News
  • Resources
  • Events
  • Membership
  • Forum
  • Contact Us

Membership

Open to clinical trials networks, clinical trial coordinating centres and clinical quality registries that support ACTA’s mission and vision and meet the membership criteria outlined.

Learn More

Newsletter

Be the first to know all ACTA events and featured news through our Newsletter.

You don’t need to be a member to subscribe!

Contact us

+61 3 8639 0770

Suite 1, L2 / 24 Albert Road
Melbourne VIC 3205 Australia

Social Media

  • Twitter
  • LinkedIn

Copyright © 2021 Australian Clinical Trials Alliance | ABN: 60 168 693 972 | Privacy Statement | Sitemap

Website by Marameo Design